ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells.

We determined the distribution of ETA and ETB receptors in pulmonary arteries from pulmonary hypertensive patients and control subjects, using in vitro autoradiography, and investigated their role in mediating the proliferative effects of endothelin-1 (ET-1) on distal human pulmonary artery smooth muscle cells (PASMCs). Distal arteries possessed more medial [125I]-ET-1 binding sites (105 ± 10 versus 45 ± 6 amol/mm2; p < 0.001) and a greater proportion of ETB receptors than proximal arteries (36 ± 3% versus 3 ± 1%; p < 0.001). Receptor density in distal arteries and lung parenchyma was twofold greater (p < 0.05) in pulmonary hypertensive patients than in control subjects. ET-1 (10− 9–10− 7 mol/L) stimulated DNA synthesis (147 ± 10% of control subjects; p < 0.05) and attenuated the antiproliferative action of cicaprost and forskolin on PASMCs, these effects being mediated via ETA and ETB receptors. Serum-stimulated proliferation was attenuated by inhibiting either endogenous ET-1 release with phosphoramidon...

[1]  M. Yacoub,et al.  Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulations. , 2001, American journal of respiratory cell and molecular biology.

[2]  J. Dupuis,et al.  Effectiveness of a Nonselective ETA/B and a Selective ETA Antagonist in Rats With Monocrotaline-Induced Pulmonary Hypertension , 2001 .

[3]  M. Yacoub,et al.  Prostacyclin Analogues Differentially Inhibit Growth of Distal and Proximal Human Pulmonary Artery Smooth Muscle Cells , 2000, Circulation.

[4]  B. Meyrick,et al.  Cell-specific differences in ET-1 system in adjacent layers of main pulmonary artery. A new source of ET-1. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[5]  J. R. Mcneill,et al.  Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. , 2000, Cardiovascular research.

[6]  B. Groves,et al.  Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. , 1999, Circulation.

[7]  A. Turner,et al.  Endothelin converting enzyme is located on α-actin filaments in smooth muscle cells , 1999 .

[8]  T. Warner,et al.  Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. , 1999, Molecular pharmacology.

[9]  Y. Fukuchi,et al.  Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. , 1999, American journal of respiratory cell and molecular biology.

[10]  David P. Williamson,et al.  Transcriptional down‐regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulation , 1999, British journal of pharmacology.

[11]  M. Gorenflo,et al.  Endothelin-1- and Endothelin-Receptors in Lung Biopsies of Patients with Pulmonary Hypertension due to Congenital Heart Disease , 1999, Clinical chemistry and laboratory medicine.

[12]  S. Rich,et al.  Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. , 1998, The New England journal of medicine.

[13]  S. Douglas.  Clinical development of endothelin receptor antagonists. , 1997, Trends in pharmacological sciences.

[14]  R. D. du Bois,et al.  Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. , 1997, The American journal of pathology.

[15]  J. Gutkowska,et al.  Endothelin receptor changes in hypoxia-induced pulmonary hypertension in the newborn piglet. , 1997, The American journal of physiology.

[16]  M. Frid,et al.  Smooth muscle cell heterogeneity in pulmonary and systemic vessels. Importance in vascular disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[17]  G. Gabbiani,et al.  Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[18]  M. Maclean,et al.  EndothelinB receptor‐mediated contraction in human pulmonary resistance arteries , 1996, British journal of pharmacology.

[19]  D. Stewart,et al.  Human pulmonary circulation is an important site for both clearance and production of endothelin-1. , 1996, Circulation.

[20]  N. Gretz,et al.  Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. , 1996, Cardiovascular research.

[21]  M. Zamora,et al.  Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. , 1996, The American journal of physiology.

[22]  S. Oparil,et al.  Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. , 1995, Journal of applied physiology.

[23]  J. Polak,et al.  Postnatal changes in endothelin-1 binding in porcine pulmonary vessels and airways. , 1995, American journal of respiratory cell and molecular biology.

[24]  C. Kanthou,et al.  The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[25]  M. Sokolovsky.  Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. , 1995, Pharmacology & therapeutics.

[26]  S. Ozaki,et al.  Synergistic inhibition by BQ‐123 and BQ‐788 of endothelin‐1‐induced contractions of the rabbit pulmonary artery , 1994, British journal of pharmacology.

[27]  S. Oparil,et al.  Increased endothelin receptor gene expression in hypoxic rat lung. , 1994, The American journal of physiology.

[28]  Y. Sugishita,et al.  Endothelin receptor subtypes in human versus rabbit pulmonary arteries. , 1994, Journal of applied physiology.

[29]  E. Levin,et al.  Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. , 1994, The Journal of biological chemistry.

[30]  Y. Hirata,et al.  Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. , 1994, Endocrinology.

[31]  J. Polak,et al.  Dilator effect of endothelins in pulmonary circulation: changes associated with chronic hypoxia. , 1993, The American journal of physiology.

[32]  S. Izumo,et al.  Cytokeratins 8 and 18 in smooth muscle cells. Detection in human coronary artery, peripheral vascular, and vein graft disease and in transplantation-associated arteriosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[33]  E. Dempsey,et al.  BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. , 1993, American journal of respiratory cell and molecular biology.

[34]  P. Weissberg,et al.  Adult human aortic smooth muscle cells in culture produce active TGF-beta. , 1993, The American journal of physiology.

[35]  D. Stewart,et al.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.

[36]  R. A. Rutherford,et al.  Differential localization of endothelin ETa and ETB binding sites in human placenta , 1993, British journal of pharmacology.

[37]  A. Castañeda,et al.  Lung Biopsy in Congenital Heart Disease: A Morphometric Approach to Pulmonary Vascular Disease , 1978, Circulation.